Another successful year for Chr. Hansen: 9% organic growth in 2017/18
Press Releases • Oct 15, 2018 06:03 GMT
Based on good progress in strategic focus areas, Chr. Hansen raises ambitions to 9-11% organic growth next year
Press Releases
Chr. Hansen acquires dairy ingredient supplier Hundsbichler
Press Releases • Oct 15, 2018 06:02 GMT
Through the acquisition of the assets of Austrian-based ingredient supplier Österreichische Laberzeugung Hundsbichler GmbH, Chr. Hansen will further expand its enzyme production and presence into the traditional segments of specialty cheeses.
Chr. Hansen Natural Colors upgrades main R&D facility and Global Expertise Center
Press Releases • Jun 28, 2018 06:12 GMT
With this expansion and modernization Chr. Hansen will be able to stay ahead of consumers’ increasing demands for natural, yet innovative food and beverage products.
Chr. Hansen reports solid organic growth of 9% in the first nine months of 2017/18
Press Releases • Jun 28, 2018 06:01 GMT
CEO Mauricio Graber: “We are pleased to report that we maintained the sales momentum in Q3"
New starter culture secures mild and creamy soft cheeses
Press Releases • Jun 14, 2018 11:19 GMT
New starter culture secures mild and creamy soft cheesesChr. Hansen’s latest launch helps cheesemakers to produce soft cheese that maintains the desired taste and texture.
New starter culture designed for Mediterranean-style white cheese
Press Releases • May 23, 2018 13:36 GMT
Chr. Hansen’s latest launch secures rich flavor, more flexibility and consistent quality for the cheesemaker
Klaus Bjerrum appointed new EVP of Natural Colors Division
Press Releases • May 08, 2018 13:02 GMT
Chr. Hansen Holding A/S has entered into an agreement with Klaus Bjerrum to take up the position of Executive Vice President of Natural Colors Division
New partnership to develop treatment for peanut allergies
Press Releases • Apr 18, 2018 03:57 GMT
Prota Therapeutics, the developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen. The partnership will assess the world’s best documented probiotic strain, LGG®, in a Phase III clinical trial to develop a treatment for peanut allergy.
Chr. Hansen expands production facilities for natural colors in North America
Press Releases • Apr 11, 2018 06:12 GMT
As the conversion wave from synthetic to natural colors continues to rise in the US market, Chr. Hansen gears up for the future
Chr. Hansen reports solid organic growth of 9% for the first half year
Press Releases • Apr 11, 2018 06:04 GMT
"We are satisfied with the progress in the first half of the year, and we maintain our overall guidance for the full year,” says CEO Cees de Jong